Skip to content

Shoreline Biosciences Is Positioned to Be a Category Leader

Our Vision

To advance transformative therapies for autoimmune disease and cancer

Our Mission

To develop the right cell, with the right edits, for the right indications

We Are Committed to Scientific and Clinical Excellence and Are Passionate About Bringing Transformative Therapies to Patients in Critical Need

Leadership Team

Mauro P. Avanzi, MD, Ph.D.,

Chief Medical Officer

Scott Forrest, Ph.D.

Chief Business Officer

Lyuda Hillman, CPA

Vice President, Controller

Leah Mitchell, Ph.D.

Vice President, Translational Pharmacology

Paschalis Sideras, PH.D.

Senior Vice President, Research

Kleanthis G. Xanthopoulos, Ph.D.

Chairman & Chief Executive Officer

Board of Directors

Kleanthis G. Xanthopoulos, Ph.D.

Chairman & Chief Executive Officer

STEVEN HOLTZMAN

Co-Founder & Director

Marios Fotiadis

Director

Christopher Fuglesang, Ph.D., J.D.

Director

Frank YU

Director

Scientific Advisory Board

William Sandborn, M.D.

Co-Founder & Advisory Board Member

Travis S. Young, Ph.d.

Advisory Board Member

Scott Antonia, M.D., Ph.D.

Advisory Board Member

SILKE PAUST, Ph.D.

Advisory Board Member

Judith Shizuru, M.D., Ph.D.

Advisory Board Member

Éric Vivier, DVM, Ph.D.

Advisory Board Member

Together Let’s Push the Boundaries of Scientific Innovation